期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
癌症生物标记物和个体化医疗 被引量:1
1
作者 窦雪琳 白春梅 《中国医学科学院学报》 CAS CSCD 北大核心 2015年第1期113-117,共5页
癌症生物标记物的发展引领癌症的诊治从最早基于肿瘤类型进行治疗,已过度到基于分子靶点开展治疗的新纪元,后者也标志着个体化治疗的开端。每一个癌症个体的分子信息都是独特的,真正的个体化治疗应该着重于个体的分子信息特征,用以指导... 癌症生物标记物的发展引领癌症的诊治从最早基于肿瘤类型进行治疗,已过度到基于分子靶点开展治疗的新纪元,后者也标志着个体化治疗的开端。每一个癌症个体的分子信息都是独特的,真正的个体化治疗应该着重于个体的分子信息特征,用以指导临床决策。 展开更多
关键词 个体化医疗 癌症生物标记 非小细胞肺癌 异体肿瘤移植
下载PDF
用以监测和预测癌症疗效的分子诊断 被引量:15
2
作者 南娟(翻译) 曹志成(校对) 《中国肺癌杂志》 CAS 2011年第7期637-641,共5页
“……许多研究证实,研发分子诊断生物标记物来监测和预测各种癌症的疗效是切实有效的……未来的研究重点是促使标记物从基础研究走向临床应用。”
关键词 癌症生物标记 循环肿瘤细胞 分子诊断 预测标记 治疗反应
下载PDF
CTHRC1和NFE2L3在结直肠癌组织中的表达及相关性 被引量:3
3
作者 陈恩碧 邹继彬 +3 位作者 黄勇波 黄伟 高翔 赖德欣 《中国当代医药》 2012年第16期8-9,共2页
目的探讨CTHRC1和NFE2L3在结直肠癌早期诊断的意义。方法收集本院2005~2011年经过病理组织学检查诊断结直肠癌的手术标本51例与非癌症的经过病理组织学检查为正常结肠和直肠组织20例,应用免疫组化检测人结直肠中CTHRC1和NFE2L3蛋白的... 目的探讨CTHRC1和NFE2L3在结直肠癌早期诊断的意义。方法收集本院2005~2011年经过病理组织学检查诊断结直肠癌的手术标本51例与非癌症的经过病理组织学检查为正常结肠和直肠组织20例,应用免疫组化检测人结直肠中CTHRC1和NFE2L3蛋白的表达情况。结果癌组织中CTHRC1表达阳性47例(92.16%),正常组织中阳性1例(5.00%),两组比较差异有统计学意义(χ2=30.13,P<0.01);NFE2L3的瘤组织阳性43例(84.43%),正常组织中6例(30.00%),两组比较差异有统计学意义(χ2=23.22,P<0.01)。CTHRC1阳性表达组中,NFE2L3的阳性表达率为72.55%(37/51);在CTHRC1阴性表达组中,NFE2L3阳性表达率为1.96%(1/51),差异有统计学意义(χ2=36.54,r:0.510;P<0.01),两者表达呈正相关。结论 CTHRC1是结直肠癌发展过程中的重要因素,而NFE2L3可以直接调节CTHRC1基因的表达,这说明通过抑制NFE2L3的活性可以减少CTHRC1的表达,进而延缓结直肠癌的进展,从而发挥其抗肿瘤的作用。 展开更多
关键词 结直肠癌 三螺旋重复胶原蛋白1 核因子(网织红细胞衍生2)样3 癌症生物标记
下载PDF
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases 被引量:983
4
作者 Xi Chen Yi Ba +26 位作者 Lijia Ma Xing Cai Yuan Yin Kehui Wang Jig ang Guo Yujing Zhang Jiangning Chen Xing Guo Qibin Li Xiaoying Li Wenjing Wang Yan Zhang Jin Wang Xueyuan Jiang Yang Xiang Chen Xu Pingping Zheng Juanbin Zhang Ruiqiang Li Hongjie Zhang Xiaobin Shang Ting Gong Guang Ning Jun Wang Ke Zen Junfeng Zhang Chen-Yu Zhang 《Cell Research》 SCIE CAS CSCD 2008年第10期997-1006,共10页
Dysregulated expression of microRNAs (miRNAs) in various tissues has been associated with a variety of diseases, including cancers. Here we demonstrate that miRNAs are present in the serum and plasma of humans and o... Dysregulated expression of microRNAs (miRNAs) in various tissues has been associated with a variety of diseases, including cancers. Here we demonstrate that miRNAs are present in the serum and plasma of humans and other animals such as mice, rats, bovine fetuses, calves, and horses. The levels of miRNAs in serum are stable, reproducible, and consistent among individuals of the same species. Employing Solexa, we sequenced all serum miRNAs of healthy Chinese subjects and found over 100 and 91 serum miRNAs in male and female subjects, respectively. We also identified specific expression patterns of serum miRNAs for lung cancer, colorectal cancer, and diabetes, providing evidence that serum miRNAs contain fingerprints for various diseases. Two non-small cell lung cancer-specific serum miRNAs obtained by Solexa were further validated in an independent trial of 75 healthy donors and 152 cancer patients, using quantitative reverse transcription polymerase chain reaction assays. Through these analyses, we conclude that serum miRNAs can serve as potential biomarkers for the detection of various cancers and other diseases. 展开更多
关键词 serum-microRNA expression profile FINGERPRINT blood-based biomarker Solexa CANCERS diabetes
下载PDF
Vascular architecture:is it a helpful histopathological biomarker for hepatocellular carcinoma? 被引量:1
5
作者 GRIZZI Fabio FRANCESCHINI Barbara +2 位作者 FIAMENGO Barbara RUSSO Carlo DIOGUARDI Nicola 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2007年第4期217-220,共4页
Hepatocellular carcinoma(HCC) remains one of the major public health problems throughout the world.Although originally associated with tumorigenic processes,liver angiogenesis has also been observed in the context of ... Hepatocellular carcinoma(HCC) remains one of the major public health problems throughout the world.Although originally associated with tumorigenic processes,liver angiogenesis has also been observed in the context of different liver in-flammatory,fibrotic,and ischemic conditions.Here we investigate the fractal dimension as a quantitator of non-Euclidean two-dimensional vascular geometry in a series of paired specimens of primary HCC and surrounding non-tumoral tissue,and discuss why this parameter might provide additional information regarding cancer behavior.The application of fractal geometry to the measurement of liver vascularity and the availability of a computer-aided quantitative method can eliminate errors in visual interpretation,and make it possible to obtain closer-to-reality numerals that are compulsory for any measurement process. 展开更多
关键词 LIVER ANGIOGENESIS Cancer Fractals GEOMETRY Biomarkers
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部